<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased cell migration and invasion lead to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and are crucial to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we explore whether FBXW7 plays any role in metastatic process </plain></SENT>
<SENT sid="2" pm="."><plain>We show that <z:mpath ids='MPATH_63'>depletion</z:mpath> of FBXW7 induces epithelial-mesenchymal transition (EMT) in human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells along with the increase in cell migration and invasion </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, FBXW7 deficiency promotes the generation of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> stem-like cells in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-sphere culture </plain></SENT>
<SENT sid="4" pm="."><plain>mTOR inhibition by <z:chebi fb="0" ids="9168">rapamycin</z:chebi> suppresses FBXW7 loss-driven EMT, invasion and stemness </plain></SENT>
<SENT sid="5" pm="."><plain>Our results define the FBXW7/mTOR axis as a novel EMT pathway that mediates <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> invasion </plain></SENT>
</text></document>